Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $58.3B |
| FY2017, ended Dec 31, 2017 | $62.4B |
| FY2018, ended Dec 31, 2018 | $50.6B |
| FY2019, ended Dec 31, 2019 | $48.8B |
| FY2020, ended Dec 31, 2020 | $29.1B |
| FY2021, ended Dec 31, 2021 | $52.0B |
| FY2022, ended Dec 31, 2022 | $76.1B |
| FY2023, ended Dec 31, 2023 | $70.2B |
| FY2024, ended Dec 31, 2024 | $67.9B |
| FY2025, ended Dec 31, 2025 | $56.3B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $68.0B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.65B |
| FY2017, ended Dec 31, 2017 | $11.2B |
| FY2018, ended Dec 31, 2018 | $17.3B |
| FY2019, ended Dec 31, 2019 | $17.4B |
| FY2020, ended Dec 31, 2020 | $11.0B |
| FY2021, ended Dec 31, 2021 | $18.6B |
| FY2022, ended Dec 31, 2022 | $25.7B |
| FY2023, ended Dec 31, 2023 | $24.2B |
| FY2024, ended Dec 31, 2024 | $23.7B |
| FY2025, ended Dec 31, 2025 | $22.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $27.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$1.10B | $2.27B |
| FY2017, ended Dec 31, 2017 | $2.58B | $4.09B |
| FY2018, ended Dec 31, 2018 | $3.42B | $7.53B |
| FY2019, ended Dec 31, 2019 | $2.73B | $7.89B |
| FY2020, ended Dec 31, 2020 | −$605M | $4.79B |
| FY2021, ended Dec 31, 2021 | $4.66B | $8.58B |
| FY2022, ended Dec 31, 2022 | $7.76B | $10.7B |
| FY2023, ended Dec 31, 2023 | $7.59B | $10.5B |
| FY2024, ended Dec 31, 2024 | $6.40B | $11.1B |
| FY2025, ended Dec 31, 2025 | $4.98B | $9.56B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.88B | $12.8B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.60B |
| FY2017, ended Dec 31, 2017 | $834M |
| FY2018, ended Dec 31, 2018 | $1.56B |
| FY2019, ended Dec 31, 2019 | $2.03B |
| FY2020, ended Dec 31, 2020 | $3.33B |
| FY2021, ended Dec 31, 2021 | $5.21B |
| FY2022, ended Dec 31, 2022 | $5.97B |
| FY2023, ended Dec 31, 2023 | $5.28B |
| FY2024, ended Dec 31, 2024 | $7.09B |
| FY2025, ended Dec 31, 2025 | $3.40B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.91B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.99B |
| FY2017, ended Dec 31, 2017 | $6.39B |
| FY2018, ended Dec 31, 2018 | $6.08B |
| FY2019, ended Dec 31, 2019 | $5.18B |
| FY2020, ended Dec 31, 2020 | $5.82B |
| FY2021, ended Dec 31, 2021 | $5.11B |
| FY2022, ended Dec 31, 2022 | $5.08B |
| FY2023, ended Dec 31, 2023 | $3.80B |
| FY2024, ended Dec 31, 2024 | $4.75B |
| FY2025, ended Dec 31, 2025 | $7.94B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $7.93B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 9.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 577M |
| FY2017, ended Dec 31, 2017 | 579M |
| FY2018, ended Dec 31, 2018 | 580M |
| FY2019, ended Dec 31, 2019 | 582M |
| FY2020, ended Dec 31, 2020 | 584M |
| FY2021, ended Dec 31, 2021 | 585M |
| FY2022, ended Dec 31, 2022 | 588M |
| FY2023, ended Dec 31, 2023 | 580M |
| FY2024, ended Dec 31, 2024 | 554M |
| FY2025, ended Dec 31, 2025 | 536M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 525M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $82.1M | $128M |
| FY2017, ended Dec 31, 2017 | $63.4M | $134M |
| FY2018, ended Dec 31, 2018 | $63.5M | $155M |
| FY2019, ended Dec 31, 2019 | $25.0M | $175M |
| FY2020, ended Dec 31, 2020 | $16.0M | $146M |
| FY2021, ended Dec 31, 2021 | $41.0M | $152M |
| FY2022, ended Dec 31, 2022 | $118M | $133M |
| FY2023, ended Dec 31, 2023 | $1.04B | $177M |
| FY2024, ended Dec 31, 2024 | $3.25B | $199M |
| FY2025, ended Dec 31, 2025 | $2.56B | $216M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.87B | $231M |
Valuation
At current price- Market Cap
- $84.5B
- P/E
- 12.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.1×
- Price / Book
- 2.7×
- EV / EBITDA
- 6.4×
Growth
Trailing 12 months- Revenue (TTM)
- $27.0B
- Revenue Growth YoY
- 19.1%
- Revenue CAGR 3Y
- −4.2%
- Revenue CAGR 5Y
- 15.5%
- EPS Growth YoY
- 24.6%
- Net Income Growth YoY
- 20.0%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 32.9%
- Net Margin
- 25.4%
- FCF Margin
- 47.3%
- Return on Equity
- 22.5%
Earnings
Trailing 12 months- Net Income
- $6.88B
- EPS (diluted)
- $12.85
- EBITDA
- $13.8B
- Operating Income
- $8.90B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $4.91B
- Total Debt
- $7.93B
- Net Debt
- $3.02B
- Total Assets
- $54.8B
- Total Liabilities
- $22.9B
- Shareholders' Equity
- $31.9B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $13.4B
- Capital Expenditure
- $580M
- Free Cash Flow
- $12.8B
Dividends and risk
Last 12 months- Dividend Yield
- 2.5%
- Dividend / Share
- $4.08
- Beta (5Y)
- 0.37
Every ratio is calculated from the company’s reported figures.